Detalhe da pesquisa
1.
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.
Cell
; 179(1): 219-235.e21, 2019 09 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31522890
2.
Preclinical mouse cancer models: a maze of opportunities and challenges.
Cell
; 163(1): 39-53, 2015 Sep 24.
Artigo
Inglês
| MEDLINE | ID: mdl-26406370
3.
Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
Nature
; 579(7798): 284-290, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32103175
4.
Exploring tumor-normal cross-talk with TranNet: Role of the environment in tumor progression.
PLoS Comput Biol
; 19(9): e1011472, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37721939
5.
Identification of essential genes for cancer immunotherapy.
Nature
; 548(7669): 537-542, 2017 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-28783722
6.
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem.
Bioinformatics
; 36(Suppl_1): i169-i176, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32657358
7.
A direct link between MITF, innate immunity, and hair graying.
PLoS Biol
; 16(5): e2003648, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29723194
8.
Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance.
Lab Invest
; 97(6): 698-705, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28092363
9.
Genetically engineered mouse models of melanoma.
Cancer
; 123(S11): 2089-2103, 2017 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28543694
10.
Stochastic modelling of single-cell gene expression adaptation reveals non-genomic contribution to evolution of tumor subclones.
bioRxiv
; 2024 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38712152
11.
Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads.
medRxiv
; 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38585974
12.
Exploring tumor-normal cross-talk with TranNet: role of the environment in tumor progression.
bioRxiv
; 2023 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36945455
13.
Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.
Pharmacol Ther
; 248: 108466, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37301330
14.
Melanoma clonal subline analysis uncovers heterogeneity-driven immunotherapy resistance mechanisms.
bioRxiv
; 2023 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37333132
15.
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Nat Commun
; 14(1): 2744, 2023 05 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37173324
16.
Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin.
Int J Cancer
; 130(1): 190-9, 2012 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21312195
17.
Making a mouse out of a molehill: how precision modeling repurposes drugs for congenital giant nevi.
Trends Cancer
; 8(8): 626-628, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35718707
18.
The Hitchhiker's Guide across a Waddington's landscape of melanoma.
Dev Cell
; 57(21): 2447-2449, 2022 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36347238
19.
Broad misappropriation of developmental splicing profile by cancer in multiple organs.
Nat Commun
; 13(1): 7664, 2022 12 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36509773
20.
A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer.
Mol Ther Oncolytics
; 24: 849-863, 2022 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35317524